DGF

Clinical trials for DGF explained in plain language.

Never miss a new study

Get alerted when new DGF trials appear

Sign up with your email to follow new studies for DGF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug aims to kickstart transplanted kidneys faster

Disease control Recruiting now

This phase 3 trial tests whether ravulizumab, given intravenously, can reduce the severity of delayed graft function (DGF) in adults at high risk after kidney transplant. DGF is when the new kidney is slow to start working, often requiring dialysis. The study will compare ravuliz…

Matched conditions: DGF

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

DGF

Get alerted when new DGF trials appear

New drug aims to kickstart transplanted kidneys faster